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different diffusion-sensitizing gradients (b = 0, 200 and 800 
s/mm2). The median tumor apparent diffusion coefficient 
(ADC) was determined at the three time points. The 
predictive potential of initial ADC, and change in ADC (ΔADC) 
during and after treatment for pathologic complete response 
(pathCR) and good response (GR) was assessed. Good 
response was defined as pathCR or near-pathCR (tumor 
regression grade [TRG] 1 or 2).  
Results: A pathCR after nCRT was found in 4 of 20 patients 
(20%), and 8 patients (40%) showed a good response. The 
ΔADCduring was significantly higher in pathCR patients 
compared to patients without pathCR, as well as in good 
responders compared to poor responders (Table 1, Figure 1-
3). Initial tumor ADC and ΔADCpost were not significantly 
related to pathologic response. ROC analysis for ΔADCduring 
resulted in an area under the curve (AUC) of 0.90 for 
discriminating pathCR from no pathCR at an optimal cut-off 
value of 28.9% (sensitivity 100%, specificity 75%, accuracy 
95%, PPV 94%, and NPV 100%). For discriminating good from 
poor responders, ΔADCduring showed an AUC of 0.92 with an 
optimal cut-off value of 20.7% (sensitivity 82%, specificity 
100%, accuracy 89%, PPV 100%, and NPV 80%).  
 
 
 
 
Conclusions: The treatment-induced change in ADC as 
determined on DW-MRI during the first 2-3 weeks of nCRT for 
esophageal cancer allows for accurate early prediction of 
pathologic response. The high sensitivity and NPV of 
ΔADCduring for predicting residual cancer are particularly 
promising when considering a patient-tailored wait-and-see 
approach with omission of surgery in the future. The high 
specificity and PPV of ΔADCduring for predicting poor response 
are promising for future considerations regarding 
modification or discontinuation of nCRT early during 
treatment.  
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Purpose/Objective: The purpose of the current study was to 
investigate the ability of pre-treatment factors and response 
signals extracted from standard CBCT images obtained during 
fractionated radiotherapy to predict the lung 
radioresponsiveness (LuRa) measured as density changes in 
follow-up CT scans for NSCLC patients. 
Materials and Methods: Follow-up CT scans acquired within 6 
months after commencement of radiotherapy (RT) were 
evaluated for 135 NSCLC patients treated with CBCT image 
guided RT to 60 or 66 Gy in 2 Gy fractions. Dose-effect curves 
were produced from follow-up CT scans by relating changes 
in regional lung density to regional planned dose using 
deformable image registration. LuRa was defined as the slope 
of a linear fit to the dose-effect curve and provides an 
objective measure of the patients' individual susceptibility to 
radiation. Cone beam signals (CBS) were obtained by 
analysing changes in lung density in CBCT images acquired 
during the treatment course. The association of LuRa with 
pre-treatment factors and CBS was investigated in terms of 
overall correlations and for the ability to predict subgroups of 
patients with high or low responsiveness. 
Results: LuRa values range from -1.1 to 6.2 HU/Gy with a 
median at 1.0 HU/Gy. Of the pre-treatment factors, age 
correlated most with LuRa on univariable analysis (R=0.31). 
CBS obtained at the 20th and 30th treatment fraction was 
significantly correlated with LuRa (R=0.19 and R=0.34, 
respectively), while the signal obtained at the 10th fraction 
only reached borderline significance (R=0.16, p=0.068). Age 
and CBS extracted at 10th, 20th, and 30th treatment fraction 
were significant in multivariable analysis and a set of models 
for predicting LuRa based on these parameters were 
established (see table). Due to the low correlations, the 
models might have limited clinical impact. However, for 
typical treatments ~15% of the patients experience a grade 
3+ pneumonitis, and the right-sided tail of the LuRa values 
contains ~15% of the data as well. Thus, a dichotomization of 
the LuRa values at 85% (2.7 HU/Gy) might be clinically 
relevant. The ability of the 10th fraction model to predict a 
low response in patients is visualized as ROC curves in the 
figure. For safe dose escalation, all high-responsive patients 
must be classified correctly. In this regime (specificity=1), 
the full model classified significantly more of the low-
responsive patients correctly than the model only including 
age (58% vs. 36%, p<0.001). 
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Conclusions: This study indicates that the effect of radiation 
dose on the local lung damage may be partially detected 
already during RT using CBCT image analysis. If a high LuRa 
value is shown to be a good surrogate endpoint for clinical 
toxicity and the results of the current investigational study 
are validated, the proposed response models may provide an 
assay for identifying a subgroup of low-responsive patients as 
potential candidates for safe dose escalation. 
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Accurate, robust, reproducible and fast delineation of 
functional tumor volumes in 3D using positron emission 
tomography (PET) has been already identified as a pressing 
challenge for an increasing number of oncology applications, 
such as image-guided radiotherapy, as well as diagnosis, 
prognosis and therapy response assessment. The main drive 
behind this interest is based on the fact that the use of 
functional imaging allows the biological characterization of 
active tumor volumes employing different tracers. There is 
therefore a growing need for accurate quantification of both 
tumor volume and associated indices of tracer accumulation, 
such as standardized uptake values, in order to refine 
detection criteria associated with various forms of cancer 
and study the relationship between overall tumor burden and 
response to therapy or survival. Following the introduction of 
the main clinical incentives behind the development of 
functional volume segmentation algorithms, the objectives of 
this presentation will be to (a). provide a critical analysis of 
the currently available segmentation methods and associated 
validation studies, (b). provide guidelines with respect to the 
clinical use of existing semi-automatic and fully-automatic 
algorithms, (c). discuss the impact of automatic functional 
segmentation algorithms within the context of therapy 
response monitoring and radiotherapy treatment planning. 
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Temporal changes of the location and shape of tumour 
targets or organs at risk during a course of treatment are 
considered one of the major obstacles to deliver high 
precision radiation therapy (RT) for a number of treatment 
sites. According to the different time scales on which these 
organ movements and deformations are expected to occur 
one differentiates between inter- and intra-fraction organ 
motions. One basic strategy to account for the effect 
of anatomical changes during RT refers to treatment plan 
adaptation that can be either achieved as the refinement of 
an existing treatment plan or as complete re-optimisation of 
treatment parameters for the new patient geometry. 
The standard scenario envisioned for a clinical workflow is 
based on a set of 3d-images of the patient in treatment 
position directly prior to treatment acquired either by in-
room imaging devices, ranging from in-room kV-CT, MV-CBCT, 
kV-CBCT or MV-CT to MRI. These images are then 
prepared for either treatment plan modification or re-
planning by fast image processing that identifies the actual 
volumes of interest relevant  for autmatic plan optimisation. 
These methods were originally designed for off-line 
modifications of established treatment plans 
to account for slowly developing anatomical changes like 
weight loss/gain of patients or radiation induced tissue 
responses. However, improved soft tissue contrast, especially 
achievable with MRI combined with ultra-fast treatment 
planning tools will allow to extend the application of this 
treatment adaptation strategy to the on-line regime, i.e., 
either directly prior to treatment or even during treatment. 
We will discuss the development and application of on-line 
treatment plan adaptation tools for inter- and intra-fraction 
changes of the patient anatomy. Starting point will be a 
dynamic patient model (DPM) which will be continously up-
dated through images acquired during the course of 
treatment. The DPM can be used to re-construct the 
delivered dose to the patient, before a new treatment plan is 
established. This second step can be either achieved by 
interactive refinement of an existing treatment plan via a 
graphical interface or by a complete re-optimisation. Both 
approaches require a different approach of online quality 
assurance. Furthermore, we will discuss the scenario of an 
online feedback loop between real-time plan adaptation and 
dynamic dose delivery concepts. 
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Intensity modulated treatments, in the two forms or IMRT 
with fixed fields and VMAT (volumetric modulated arc 
therapy) with rotational approach, is possible only thanks to 
the inverse process for planning the treatments. This opens 
the challenge to translate the desired dose distributions, 
including the broad knowledges on the toxicity dose levels for 
the critical structures, into the proper dose-volume 
